Drug Shortage Report for LITHMAX
Report ID | 221857 |
Drug Identification Number | 02266695 |
Brand name | LITHMAX |
Common or Proper name | LITHMAX |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | LITHIUM CARBONATE |
Strength(s) | 300MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | N05AN |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-04-01 |
Actual start date | |
Estimated end date | 2024-06-20 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-04-02 | English | Compare |
v2 | 2024-03-11 | French | Compare |
v1 | 2024-03-11 | English | Compare |
Showing 1 to 3 of 3